These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23963759)

  • 1. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.
    Quattrocelli M; Crippa S; Montecchiani C; Camps J; Cornaglia AI; Boldrin L; Morgan J; Calligaro A; Casasco A; Orlacchio A; Gijsbers R; D'Hooge J; Toelen J; Janssens S; Sampaolesi M
    J Am Heart Assoc; 2013 Aug; 2(4):e000284. PubMed ID: 23963759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.
    Sabharwal R; Weiss RM; Zimmerman K; Domenig O; Cicha MZ; Chapleau MW
    Exp Physiol; 2015 Jul; 100(7):776-95. PubMed ID: 25921929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.
    Cooley N; Ouyang K; McMullen JR; Kiriazis H; Sheikh F; Wu W; Mu Y; Du XJ; Chen J; Woodcock EA
    Circ Heart Fail; 2013 Mar; 6(2):318-25. PubMed ID: 23258573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
    Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
    Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epicatechin inhibits development of dilated cardiomyopathy in δ sarcoglycan null mouse.
    De Los Santos S; Palma-Flores C; Zentella-Dehesa A; Canto P; Coral-Vázquez RM
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1188-1195. PubMed ID: 30143409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA-125b-5p expression in patients with dilated cardiomyopathy combined with heart failure and its effect on myocardial fibrosis.
    Zhang Y; Deng D; Huang Q; Wu J; Xiang Y; Ou B
    Scand Cardiovasc J; 2024 Dec; 58(1):2373083. PubMed ID: 39024033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dilated cardiomyopathy in Bmal1-deficient mice.
    Lefta M; Campbell KS; Feng HZ; Jin JP; Esser KA
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H475-85. PubMed ID: 22707558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy.
    Kyrychenko S; Kyrychenko V; Badr MA; Ikeda Y; Sadoshima J; Shirokova N
    Cardiovasc Res; 2015 Dec; 108(3):324-34. PubMed ID: 26503985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.
    Wang D; Gladysheva IP; Fan TH; Sullivan R; Houng AK; Reed GL
    Hypertension; 2014 Mar; 63(3):514-9. PubMed ID: 24379183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
    Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
    J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.
    Bauer R; Macgowan GA; Blain A; Bushby K; Straub V
    Cardiovasc Res; 2008 Sep; 79(4):652-61. PubMed ID: 18495669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
    Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.
    Xie Y; Li M; Wang X; Zhang X; Peng T; Yang Y; Zou Y; Ge J; Chen H; Chen R
    PLoS One; 2013; 8(8):e72158. PubMed ID: 23977238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic AAV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice.
    Pozsgai ER; Griffin DA; Heller KN; Mendell JR; Rodino-Klapac LR
    Mol Ther; 2017 Apr; 25(4):855-869. PubMed ID: 28284983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
    Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
    Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
    Sabharwal R; Chapleau MW
    Exp Physiol; 2014 Apr; 99(4):627-31. PubMed ID: 24334334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.